COMBINED MODALITY THERAPY FOR ADVANCED HODGKINS-DISEASE - 15-YEAR FOLLOW-UP DATA

被引：98

作者：

PROSNITZ, LR

FARBER, LR

KAPP, DS

SCOTT, J

BERTINO, JR

FISCHER, JJ

CADMAN, EC

机构：

[1] YALE UNIV, SCH MED, DEPT MED, NEW HAVEN, CT 06510 USA

[2] YALE UNIV, SCH MED, DEPT THERAPEUT RADIOL, NEW HAVEN, CT 06510 USA

[3] STANFORD UNIV, MED CTR, SCH MED, DEPT THERAPEUT RADIOL, STANFORD, CA 94305 USA

[4] MEM SLOAN KETTERING CANC CTR, NEW YORK, NY 10021 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1988年 / 6卷 / 04期

关键词：

D O I：

10.1200/JCO.1988.6.4.603

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：603 / 612

页数：10

共 48 条

[1] 2ND LYMPHOID MALIGNANT NEOPLASMS OCCURRING IN PATIENTS TREATED FOR HODGKINS-DISEASE [J].

ARMITAGE, JO ;

DICK, FR ;

GOEKEN, JA ;

FOUCAR, MK ;

GINGRICH, RD .

ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (03) :445-450

[2] BCVPP CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE - EVIDENCE FOR GREATER DURATION OF COMPLETE REMISSION, GREATER SURVIVAL, AND LESS TOXICITY THAN WITH A MOPP REGIMEN [J].

BAKEMEIER, RF ;

ANDERSON, JR ;

COSTELLO, W ;

ROSNER, G ;

HORTON, J ;

GLICK, JH ;

HINES, JD ;

BERARD, CW ;

DEVITA, VT .

ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) :447-456

[3]

BARTOLUCCI AA, 1983, CANCER, V52, P2209, DOI 10.1002/1097-0142(19831215)52:12<2209::AID-CNCR2820521206>3.0.CO

[4]

2-6

[5]

BLOOMFIELD CD, 1982, CANCER TREAT REP, V66, P835

[6]

BOIVIN JF, 1984, JNCI-J NATL CANCER I, V72, P233

[7]

BONADONNA G, 1985, SEMIN ONCOL, V12, P1

[8] ALTERNATING NON-CROSS-RESISTANT COMBINATION CHEMOTHERAPY OR MOPP IN STAGE-IV HODGKINS-DISEASE - A REPORT OF 8-YEAR RESULTS [J].

BONADONNA, G ;

VALAGUSSA, P ;

SANTORO, A .

ANNALS OF INTERNAL MEDICINE, 1986, 104 (06) :739-746

[9]

CARBONE PP, 1971, CANCER RES, V31, P1860

[10] SECONDARY NEOPLASMS IN PATIENTS TREATED FOR CANCER - ETIOLOGY AND PERSPECTIVE [J].

COLEMAN, CN .

RADIATION RESEARCH, 1982, 92 (01) :188-200

← 1 2 3 4 5 →